IDiyas

For the Inventor, By the Inventor

Edison, NJ, United States of America

David H Shih

USPTO Granted Patents = 30

Average Co-Inventor Count = 2.0

ph-index = 13

Forward Citations = 407(Granted Patents)


Location History:

  • Manalapan, NJ (US) (1982 - 1988)
  • Edison, NJ (US) (1979 - 1989)
  • West Windsor, NJ (US) (1991)

Company Filing History:

goldMedal30 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1979-1991

Loading Chart...
30 patents (USPTO):Explore Patents
1. 5034385 - 2-(heteroarylsubstituted)phenyl carbapenem antibacterial agents (1991-07-23),
2. 4839352 - N-acyl derivatives of thienamycin (1989-06-13),
3. 4748238 - Crystalline (1988-05-31),
4. 4729993 - Carbapenems and 1-methylcarbapenems having an externally alkylated mono- (1988-03-08),
5. 4696923 - 6-[1-hydroxyethyl]-2-SR.sup.8 (1987-09-29),
6. 4600713 - 1-, 6- and 2-substituted-1-carba-2-penem-3-carboxylic acids (1986-07-15),
7. 4582643 - 6-(1-hydroxyethyl)-2-(2-amin (1986-04-15),
8. 4465632 - Process for preparing 1-6-and 2-substituted-1-carba-2-penem-3-carboxylic (1984-08-14),
9. 4460507 - Process for the preparation of thienamycin (1984-07-17),
10. 4397861 - N- And carboxyl derivatives of thienamycin (1983-08-09),
11. 4372965 - 6-, 1- And 2-substituted-thio-1-carbadethiapen-2-em-3-carboxylic acid (1983-02-08),
12. 4350631 - 6- and 4-Substituted-1-azabicyclo[3.2.0]heptan-3,7-dione-2-carboxylates (1982-09-21),
13. 4341791 - 6-, 2- and 1,1-Disubstituted-1-carbadethiapen-2-em-3-carboxylic acid (1982-07-27),
14. 4341706 - Process for the preparation of carbapenem antibiotics (1982-07-27),
15. 4341705 - Thienamycin derivatives (1982-07-27),

Title: Innovations and Contributions of David H. Shih

Introduction

David H. Shih, a prominent inventor based in Edison, NJ, has made significant contributions to the field of antibacterial agents. With an impressive portfolio of 30 patents, Shih is recognized for his innovative work in developing effective pharmaceutical solutions.

Latest Patents

Two of Shih's latest patents highlight his expertise in the area of antibiotic research. The first patent focuses on 2-(heteroarylsubstituted)phenyl carbapenem antibacterial agents, which are useful in combating bacterial infections. The second patent discloses N-acyl derivatives of the antibiotic thienamycin, represented by specific structural formulas that emphasize their potential as effective antibiotics. These derivatives, along with their pharmaceutically acceptable salts, offer promising applications in treating infections requiring antibiotic intervention.

Career Highlights

Shih is currently employed at Merck & Company, Inc., a leading global healthcare company that is at the forefront of pharmaceutical innovation. His contributions within the company have solidified his reputation as a key inventor in the development of next-generation antibacterial therapies.

Collaborations

Throughout his career, David H. Shih has collaborated with several notable professionals, including Burton G. Christensen and John Hannah. These partnerships have enhanced his research and have played an essential role in the advancement of his projects, ultimately leading to the successful development of his patented innovations.

Conclusion

David H. Shih stands out as an influential figure in the pharmaceutical industry, especially in the realm of antibacterial agents. His ongoing dedication to innovation and collaboration with esteemed colleagues contributes to his significant impact on public health and medicine. As he continues to develop groundbreaking solutions at Merck & Company, he remains a vital asset to the field of pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…